(firstQuint)A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia.

 The Phase II study is to establish the maximum tolerated dose of i.

v.

 IOP Injection in Part 1 and to evaluate the safety and efficacy of the maximally tolerated dose of IOP Injection with different infusions schemes in Part 2.

.

 A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia@highlight

The purpose is to evaluate the efficacy and safety of IOP Injection for the treatment of iron-deficient anemia (IDA).

